• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparison of the relative efficacy and safety of low-molecular-weight heparin and unfractionated heparin for the treatment of venous thrombosis.

作者信息

Hirsh J

机构信息

Hamilton Civic Hospitals Research Centre, Henderson General Division, Ontario, Canada.

出版信息

Semin Thromb Hemost. 1996;22 Suppl 2:7-12; discussion 29-30.

PMID:8946613
Abstract
摘要

相似文献

1
Comparison of the relative efficacy and safety of low-molecular-weight heparin and unfractionated heparin for the treatment of venous thrombosis.低分子量肝素与普通肝素治疗静脉血栓形成的相对疗效和安全性比较。
Semin Thromb Hemost. 1996;22 Suppl 2:7-12; discussion 29-30.
2
Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.低分子量肝素与普通肝素治疗深静脉血栓形成的相对疗效和安全性比较。
Semin Hematol. 1997 Oct;34(4 Suppl 4):20-5.
3
Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?静脉血栓栓塞症的治疗：普通肝素还是低分子量肝素？
Haematologica. 1995 Mar-Apr;80(2 Suppl):78-83.
4
Low molecular weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical results.低分子量肝素用于静脉血栓形成的院外治疗：理论依据与临床结果
Thromb Haemost. 1997 Jul;78(1):689-92.
5
Should low-molecular-weight heparins replace unfractionated heparin as the agent of choice for adults with deep venous thrombosis?
J Fam Pract. 1998 Sep;47(3):185-92.
6
Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.肝素和低分子量肝素治疗静脉血栓栓塞症。抗凝监测的黄昏。
Int Angiol. 1998 Dec;17(4):213-24.
7
[Treatment of venous thrombosis with low molecular weight heparin. Progress and outlook].
Bull Acad Natl Med. 1997 May;181(5):875-83; discussion 883-5.
8
Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.低分子量肝素与普通肝素用于重大外科手术后血栓形成的预防：既往荟萃分析的更新
Br J Surg. 1997 Jun;84(6):750-9.
9
Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.低分子量肝素与普通肝素用于重大手术干预后血栓形成的预防：既往荟萃分析的更新
Br J Surg. 1998 Jun;85(6):872. doi: 10.1046/j.1365-2168.1998.00844.x.
10
Low-molecular-weight heparin for the treatment of deep vein thrombosis.低分子量肝素用于治疗深静脉血栓形成。
Pharmacotherapy. 1998 Jul-Aug;18(4):748-58.

引用本文的文献

1
Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis.肝素与癌症再探讨：涉及血小板、P选择素、癌黏蛋白和肿瘤转移的机制联系
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3352-7. doi: 10.1073/pnas.061615598.
2
Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.肝素和硫酸乙酰肝素糖胺聚糖与选择素的差异相互作用。关于使用普通肝素和低分子量肝素作为治疗药物的意义。
J Clin Invest. 1998 Feb 15;101(4):877-89. doi: 10.1172/JCI1509.